Today we are joined by Ivan Kairatov, a biopharma expert with deep insights into the intersection of technology and medical innovation. For decades, the goal of HIV treatment has been management—using antiretroviral therapy to suppress the virus to undetectable levels. A true cure has remained
Beyond the primary battle against tumors, many cancer patients face a debilitating secondary war against cachexia, a profound wasting syndrome that silently erodes the body and spirit. This severe metabolic condition, marked by unintentional weight loss and muscle deterioration, significantly
In the high-stakes world of biopharmaceutical development, the line between a groundbreaking success and a costly failure is often defined by the unforgiving logic of statistical significance, a reality Nektar Therapeutics recently confronted with its autoimmune drug, rezpegaldesleukin. The company
For individuals born with the rare and debilitating genetic disorder Wiskott-Aldrich syndrome, the hope for a cure has long been shadowed by the immense challenge of finding a perfectly matched stem cell donor. This condition, which severely compromises the immune system and blood clotting, leaves
A landmark investigation into the intestinal microbiome has uncovered a remarkably specific and nuanced connection to the progression of multiple sclerosis (MS), revolving around a deceptive cellular mechanism known as "molecular mimicry." Collaborative research from the University of Basel and the
We're joined today by Ivan Kairatov, a leading biopharma expert whose work is at the forefront of understanding our complex relationship with the microscopic world inside us. His team's recent discoveries are reshaping how we view the common fungus Candida albicans —not just as a potential threat,
